世界のβ-ニコチンアミドモノヌクレオチド市場予測（～2028年）：98％以上、98％以下

• 英文タイトル：Global Beta-Nicotinamide Mononucleotide Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

• レポートコード：GIR-22E0670 • 出版社/出版日：GlobalInfoResearch / 2022年5月 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（2~3営業日） • 産業分類：化学＆材料

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

β-ニコチンアミドモノヌクレオチド市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界のβ-ニコチンアミドモノヌクレオチドの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 β-ニコチンアミドモノヌクレオチド市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・98％以上、98％以下 用途別セグメントは次のように区分されます。 ・健康食品、化粧品、その他 世界のβ-ニコチンアミドモノヌクレオチド市場の主要な市場プレーヤーは以下のとおりです。 ・GeneHarbor、Herbalmax、Genex Formulas、Shinkowa Pharmaceutical、Maac10 Formulas、EffePharm、Bontac、CELFULL、Kingdomway 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、β-ニコチンアミドモノヌクレオチド製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なβ-ニコチンアミドモノヌクレオチドメーカーの企業概要、2019年～2022年までのβ-ニコチンアミドモノヌクレオチドの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なβ-ニコチンアミドモノヌクレオチドメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別β-ニコチンアミドモノヌクレオチドの販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までのβ-ニコチンアミドモノヌクレオチドの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのβ-ニコチンアミドモノヌクレオチド市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、およびβ-ニコチンアミドモノヌクレオチドの産業チェーンを掲載しています。 ・第13、14、15章では、β-ニコチンアミドモノヌクレオチドの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：GeneHarbor、Herbalmax、Genex Formulas、Shinkowa Pharmaceutical、Maac10 Formulas、EffePharm、Bontac、CELFULL、Kingdomway ・メーカー別市場シェア ・地域別市場分析2017年-2028年 ・種類別分析2017年-2028年：98％以上、98％以下 ・用途別分析2017年-2028年：健康食品、化粧品、その他 ・β-ニコチンアミドモノヌクレオチドの北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ ・β-ニコチンアミドモノヌクレオチドのヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア ・β-ニコチンアミドモノヌクレオチドのアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア ・β-ニコチンアミドモノヌクレオチドの南米市場規模2017年-2028年：ブラジル、アルゼンチン ・β-ニコチンアミドモノヌクレオチドの中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Beta-Nicotinamide Mononucleotide market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Beta-Nicotinamide Mononucleotide market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Health Care Products accounting for % of the Beta-Nicotinamide Mononucleotide global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Above 98% segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Beta-Nicotinamide Mononucleotide include GeneHarbor, Herbalmax, Genex Formulas, Shinkowa Pharmaceutical, and Maac10 Formulas, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Beta-Nicotinamide Mononucleotide market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Above 98%
Below 98%
Market segment by Application can be divided into
Health Care Products
Cosmetics
Others
The key market players for global Beta-Nicotinamide Mononucleotide market are listed below:
GeneHarbor
Herbalmax
Genex Formulas
Shinkowa Pharmaceutical
Maac10 Formulas
EffePharm
Bontac
CELFULL
Kingdomway
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Beta-Nicotinamide Mononucleotide product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Beta-Nicotinamide Mononucleotide, with price, sales, revenue and global market share of Beta-Nicotinamide Mononucleotide from 2019 to 2022.
Chapter 3, the Beta-Nicotinamide Mononucleotide competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Beta-Nicotinamide Mononucleotide breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Beta-Nicotinamide Mononucleotide market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Beta-Nicotinamide Mononucleotide.
Chapter 13, 14, and 15, to describe Beta-Nicotinamide Mononucleotide sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Beta-Nicotinamide Mononucleotide Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Beta-Nicotinamide Mononucleotide Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Above 98%
1.2.3 Below 98%
1.3 Market Analysis by Application
1.3.1 Overview: Global Beta-Nicotinamide Mononucleotide Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Health Care Products
1.3.3 Cosmetics
1.3.4 Others
1.4 Global Beta-Nicotinamide Mononucleotide Market Size & Forecast
1.4.1 Global Beta-Nicotinamide Mononucleotide Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Beta-Nicotinamide Mononucleotide Sales in Volume (2017-2028)
1.4.3 Global Beta-Nicotinamide Mononucleotide Price (2017-2028)
1.5 Global Beta-Nicotinamide Mononucleotide Production Capacity Analysis
1.5.1 Global Beta-Nicotinamide Mononucleotide Total Production Capacity (2017-2028)
1.5.2 Global Beta-Nicotinamide Mononucleotide Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Beta-Nicotinamide Mononucleotide Market Drivers
1.6.2 Beta-Nicotinamide Mononucleotide Market Restraints
1.6.3 Beta-Nicotinamide Mononucleotide Trends Analysis
2 Manufacturers Profiles
2.1 GeneHarbor
2.1.1 GeneHarbor Details
2.1.2 GeneHarbor Major Business
2.1.3 GeneHarbor Beta-Nicotinamide Mononucleotide Product and Services
2.1.4 GeneHarbor Beta-Nicotinamide Mononucleotide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Herbalmax
2.2.1 Herbalmax Details
2.2.2 Herbalmax Major Business
2.2.3 Herbalmax Beta-Nicotinamide Mononucleotide Product and Services
2.2.4 Herbalmax Beta-Nicotinamide Mononucleotide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Genex Formulas
2.3.1 Genex Formulas Details
2.3.2 Genex Formulas Major Business
2.3.3 Genex Formulas Beta-Nicotinamide Mononucleotide Product and Services
2.3.4 Genex Formulas Beta-Nicotinamide Mononucleotide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Shinkowa Pharmaceutical
2.4.1 Shinkowa Pharmaceutical Details
2.4.2 Shinkowa Pharmaceutical Major Business
2.4.3 Shinkowa Pharmaceutical Beta-Nicotinamide Mononucleotide Product and Services
2.4.4 Shinkowa Pharmaceutical Beta-Nicotinamide Mononucleotide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Maac10 Formulas
2.5.1 Maac10 Formulas Details
2.5.2 Maac10 Formulas Major Business
2.5.3 Maac10 Formulas Beta-Nicotinamide Mononucleotide Product and Services
2.5.4 Maac10 Formulas Beta-Nicotinamide Mononucleotide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 EffePharm
2.6.1 EffePharm Details
2.6.2 EffePharm Major Business
2.6.3 EffePharm Beta-Nicotinamide Mononucleotide Product and Services
2.6.4 EffePharm Beta-Nicotinamide Mononucleotide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Bontac
2.7.1 Bontac Details
2.7.2 Bontac Major Business
2.7.3 Bontac Beta-Nicotinamide Mononucleotide Product and Services
2.7.4 Bontac Beta-Nicotinamide Mononucleotide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 CELFULL
2.8.1 CELFULL Details
2.8.2 CELFULL Major Business
2.8.3 CELFULL Beta-Nicotinamide Mononucleotide Product and Services
2.8.4 CELFULL Beta-Nicotinamide Mononucleotide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Kingdomway
2.9.1 Kingdomway Details
2.9.2 Kingdomway Major Business
2.9.3 Kingdomway Beta-Nicotinamide Mononucleotide Product and Services
2.9.4 Kingdomway Beta-Nicotinamide Mononucleotide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Beta-Nicotinamide Mononucleotide Breakdown Data by Manufacturer
3.1 Global Beta-Nicotinamide Mononucleotide Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Beta-Nicotinamide Mononucleotide Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Beta-Nicotinamide Mononucleotide
3.4 Market Concentration Rate
3.4.1 Top 3 Beta-Nicotinamide Mononucleotide Manufacturer Market Share in 2021
3.4.2 Top 6 Beta-Nicotinamide Mononucleotide Manufacturer Market Share in 2021
3.5 Global Beta-Nicotinamide Mononucleotide Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Beta-Nicotinamide Mononucleotide Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Beta-Nicotinamide Mononucleotide Market Size by Region
4.1.1 Global Beta-Nicotinamide Mononucleotide Sales in Volume by Region (2017-2028)
4.1.2 Global Beta-Nicotinamide Mononucleotide Revenue by Region (2017-2028)
4.2 North America Beta-Nicotinamide Mononucleotide Revenue (2017-2028)
4.3 Europe Beta-Nicotinamide Mononucleotide Revenue (2017-2028)
4.4 Asia-Pacific Beta-Nicotinamide Mononucleotide Revenue (2017-2028)
4.5 South America Beta-Nicotinamide Mononucleotide Revenue (2017-2028)
4.6 Middle East and Africa Beta-Nicotinamide Mononucleotide Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Beta-Nicotinamide Mononucleotide Sales in Volume by Type (2017-2028)
5.2 Global Beta-Nicotinamide Mononucleotide Revenue by Type (2017-2028)
5.3 Global Beta-Nicotinamide Mononucleotide Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Beta-Nicotinamide Mononucleotide Sales in Volume by Application (2017-2028)
6.2 Global Beta-Nicotinamide Mononucleotide Revenue by Application (2017-2028)
6.3 Global Beta-Nicotinamide Mononucleotide Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Beta-Nicotinamide Mononucleotide Sales by Type (2017-2028)
7.2 North America Beta-Nicotinamide Mononucleotide Sales by Application (2017-2028)
7.3 North America Beta-Nicotinamide Mononucleotide Market Size by Country
7.3.1 North America Beta-Nicotinamide Mononucleotide Sales in Volume by Country (2017-2028)
7.3.2 North America Beta-Nicotinamide Mononucleotide Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Beta-Nicotinamide Mononucleotide Sales by Type (2017-2028)
8.2 Europe Beta-Nicotinamide Mononucleotide Sales by Application (2017-2028)
8.3 Europe Beta-Nicotinamide Mononucleotide Market Size by Country
8.3.1 Europe Beta-Nicotinamide Mononucleotide Sales in Volume by Country (2017-2028)
8.3.2 Europe Beta-Nicotinamide Mononucleotide Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Beta-Nicotinamide Mononucleotide Sales by Type (2017-2028)
9.2 Asia-Pacific Beta-Nicotinamide Mononucleotide Sales by Application (2017-2028)
9.3 Asia-Pacific Beta-Nicotinamide Mononucleotide Market Size by Region
9.3.1 Asia-Pacific Beta-Nicotinamide Mononucleotide Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Beta-Nicotinamide Mononucleotide Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Beta-Nicotinamide Mononucleotide Sales by Type (2017-2028)
10.2 South America Beta-Nicotinamide Mononucleotide Sales by Application (2017-2028)
10.3 South America Beta-Nicotinamide Mononucleotide Market Size by Country
10.3.1 South America Beta-Nicotinamide Mononucleotide Sales in Volume by Country (2017-2028)
10.3.2 South America Beta-Nicotinamide Mononucleotide Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Beta-Nicotinamide Mononucleotide Sales by Type (2017-2028)
11.2 Middle East & Africa Beta-Nicotinamide Mononucleotide Sales by Application (2017-2028)
11.3 Middle East & Africa Beta-Nicotinamide Mononucleotide Market Size by Country
11.3.1 Middle East & Africa Beta-Nicotinamide Mononucleotide Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Beta-Nicotinamide Mononucleotide Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Beta-Nicotinamide Mononucleotide and Key Manufacturers
12.2 Manufacturing Costs Percentage of Beta-Nicotinamide Mononucleotide
12.3 Beta-Nicotinamide Mononucleotide Production Process
12.4 Beta-Nicotinamide Mononucleotide Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Beta-Nicotinamide Mononucleotide Typical Distributors
13.3 Beta-Nicotinamide Mononucleotide Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

---